pubmed-article:9181492 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:9181492 | lifeskim:mentions | umls-concept:C0015780 | lld:lifeskim |
pubmed-article:9181492 | lifeskim:mentions | umls-concept:C1882598 | lld:lifeskim |
pubmed-article:9181492 | lifeskim:mentions | umls-concept:C0033306 | lld:lifeskim |
pubmed-article:9181492 | lifeskim:mentions | umls-concept:C0178601 | lld:lifeskim |
pubmed-article:9181492 | lifeskim:mentions | umls-concept:C0597879 | lld:lifeskim |
pubmed-article:9181492 | lifeskim:mentions | umls-concept:C0205146 | lld:lifeskim |
pubmed-article:9181492 | lifeskim:mentions | umls-concept:C0205263 | lld:lifeskim |
pubmed-article:9181492 | lifeskim:mentions | umls-concept:C0037239 | lld:lifeskim |
pubmed-article:9181492 | pubmed:issue | 5 | lld:pubmed |
pubmed-article:9181492 | pubmed:dateCreated | 1997-7-30 | lld:pubmed |
pubmed-article:9181492 | pubmed:abstractText | Injection of dopamine or dopamine receptor subtype agonists facilitates the expression of lordosis in estrogen-primed female rats. The D1 receptor specific agonist, SKF-38393, facilitates lordosis in estradiol-primed female rats via a process that requires progestin receptors. Based on these data, neuronal response to the D1 receptor agonist SKF-38393 was assessed by expression of the immediate early gene protein, Fos. In the first experiment we examined the modulation of Fos expression by D1 agonists in progestin receptor-containing areas of estradiol-primed female rat brain. In the second experiment we examined if there are progestin if there are progestin receptor-containing cells that respond to stimulation of D1 receptors with increased Fos expression. Ten to 14 days following ovariectomy and stereotaxic surgery, animals were injected with 5 micrograms estradiol benzoate. Forty eight h later they were injected intracerebroventricularly with 100 ng of SKF-38393 or saline. One h following injection animals were perfused, and brain sections immunostained for Fos protein. Results from the first experiment suggest that SKF-38393 increased the total number of Fos immunoreactive cells in the mid-ventromedial hypothalamic nucleus/ventrolateral portion (VMHVL), the caudal VMHVL, the paraventricular hypothalamic nucleus and the caudate putamen. In the medial preoptic area, the rostral VMHVL and the arcuate hypothalamic nucleus, there was a significant increase in the number of darkly stained Fos-immunoreactive cells following the SKF-38393 treatment. In the second study, SKF-38393 increased the number of progestin receptor-containing cells which contained Fos immunoreactivity in the caudal VMHVL. The results suggest potential sites of action for the facilitation of sexual behavior by centrally administered D1 agonists. | lld:pubmed |
pubmed-article:9181492 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9181492 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9181492 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9181492 | pubmed:language | eng | lld:pubmed |
pubmed-article:9181492 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9181492 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:9181492 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9181492 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9181492 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9181492 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9181492 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9181492 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9181492 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:9181492 | pubmed:month | May | lld:pubmed |
pubmed-article:9181492 | pubmed:issn | 0953-8194 | lld:pubmed |
pubmed-article:9181492 | pubmed:author | pubmed-author:BlausteinJ... | lld:pubmed |
pubmed-article:9181492 | pubmed:author | pubmed-author:MeredithJ MJM | lld:pubmed |
pubmed-article:9181492 | pubmed:author | pubmed-author:AugerA PAP | lld:pubmed |
pubmed-article:9181492 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:9181492 | pubmed:volume | 9 | lld:pubmed |
pubmed-article:9181492 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:9181492 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:9181492 | pubmed:pagination | 385-94 | lld:pubmed |
pubmed-article:9181492 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
pubmed-article:9181492 | pubmed:meshHeading | pubmed-meshheading:9181492-... | lld:pubmed |
pubmed-article:9181492 | pubmed:meshHeading | pubmed-meshheading:9181492-... | lld:pubmed |
pubmed-article:9181492 | pubmed:meshHeading | pubmed-meshheading:9181492-... | lld:pubmed |
pubmed-article:9181492 | pubmed:meshHeading | pubmed-meshheading:9181492-... | lld:pubmed |
pubmed-article:9181492 | pubmed:meshHeading | pubmed-meshheading:9181492-... | lld:pubmed |
pubmed-article:9181492 | pubmed:meshHeading | pubmed-meshheading:9181492-... | lld:pubmed |
pubmed-article:9181492 | pubmed:meshHeading | pubmed-meshheading:9181492-... | lld:pubmed |
pubmed-article:9181492 | pubmed:meshHeading | pubmed-meshheading:9181492-... | lld:pubmed |
pubmed-article:9181492 | pubmed:meshHeading | pubmed-meshheading:9181492-... | lld:pubmed |
pubmed-article:9181492 | pubmed:meshHeading | pubmed-meshheading:9181492-... | lld:pubmed |
pubmed-article:9181492 | pubmed:meshHeading | pubmed-meshheading:9181492-... | lld:pubmed |
pubmed-article:9181492 | pubmed:meshHeading | pubmed-meshheading:9181492-... | lld:pubmed |
pubmed-article:9181492 | pubmed:meshHeading | pubmed-meshheading:9181492-... | lld:pubmed |
pubmed-article:9181492 | pubmed:year | 1997 | lld:pubmed |
pubmed-article:9181492 | pubmed:articleTitle | D1 dopamine receptor agonist (SKF-38393) induction of Fos immunoreactivity in progestin receptor-containing areas of female rat brain. | lld:pubmed |
pubmed-article:9181492 | pubmed:affiliation | Psychology Department, University of Massachusetts, Amherst 01003, USA. | lld:pubmed |
pubmed-article:9181492 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:9181492 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9181492 | lld:pubmed |